Delivery Order SPE2DR25D3103-SPE2DR26F9F99
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $7,657.65. This non-competitive, firm fixed-price delivery order is expected to be completed by June 16, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,907.40 by the Defense Logistics Agency on November 5, 2025, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 6, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $3,832.33 to supply Trulicity 0.75 mg/0.5 ml pens. This competitive, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and represents a continuation of the company's pharmaceutical supply services supporting federal military and veteran healthcare systems. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens valued at $4,911.97 on August 25, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle extending through December 2026. The delivery order is set to be completed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $4,504.50. This is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,788.24 for Trulicity 1.5 mg/0.5 ml pens on October 17, 2025, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,822.90 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, which was not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with the...
- AmerisourceBergen Drug Corp was awarded a $11,761.50 firm fixed price delivery order by the Defense Logistics Agency (DLA) on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of November 5, 2025, with performance to be conducted at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transactional award under AmerisourceBergen's broader...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F99Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 17, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens valued at $4,595.35. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of November 18, 2025. The award supports federal medical procurement needs, particularly for military and veteran healthcare systems, as part of the company's ongoing pharmaceutical supply responsibilities to the Department of Defense. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The Defense Logistics Agency's Medical Supply Chain relies on AmerisourceBergen's established vendor capabilities to deliver critical pharmaceutical products efficiently to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 11/17/25 |